via Pioneering Minds
A drug molecule “invented” by artificial intelligence (AI) will be used in human trials in a world first for machine learning in medicine.
It was created by British start-up Exscientia and Japanese pharmaceutical firm Sumitomo Dainippon Pharma.
The drug will be used to treat patients who have obsessive-compulsive disorder (OCD).
Typically, drug development takes about five years to get to trial, but the AI drug took just 12 months.
Exscienta chief executive Prof Andrew Hopkins described it as a “key milestone in drug discovery”.
He told the BBC: “We have seen AI for diagnosing patients and for analysing patient data and scans, but this is a direct use of AI in the creation of a new medicine.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
AI designed drug
- AI model mimics randomized clinical trials for determining optimal stroke prevention treatment
Scientists have designed a new artificial intelligence model that ... Zhang envisions a day – pending Food and Drug Administration approval of AI as a decision-support tool – when clinicians could use ...
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
Researchers from the University of Cambridge have designed and used an artificial-intelligence (AI)-based approach to advance drug design and accelerate the search for Parkinson’s disease (PD) ...
- Xaira Launches with $1 Billion to Pioneer AI-Driven Drug Discovery
Xaira Therapeutics, an AI drug discovery startup, recently launched with a remarkable $1 billion funding, backed by prominent investors like ARCH Venture Partners and Foresite Labs. The company, led ...
- ETH develops AI algorithm for drug discovery based on 3D protein surface
Several diabetes drugs used today increase the activity of PPARs, which causes the cells to absorb more sugar from the blood and the blood sugar level to fall. The AI designed new molecules that ...
- Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval
Clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine announces that it has received approval from the U.S. Food and Drug Administration for its Investigational ...
Go deeper with Google Headlines on:
AI designed drug
[google_news title=”” keyword=”AI designed drug” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Machine learning in medicine
- AISAP announces $13M seed for AI-powered ultrasounds that offer results in minutes
AISAP’s Point-of-Care Assisted Diagnosis (POCAD) delivers results in as little as five minutes, compared to other ultrasound procedures that can take hours or even days for results to become available ...
- Machine learning harnessed toenhance high-power lasers
The experiment took place at the ELI Beamlines Facility in the Czech Republic, where the researchers utilised the state-of-the-art High-Repetition-Rate Advanced Petawatt Laser System (L3-HAPLS) to ...
- Machine learning tool identifies rare, undiagnosed immune disorders through patients' electronic health records
Researchers say a machine learning tool can identify many patients with rare, undiagnosed diseases years earlier than current methods, potentially improving outcomes and reducing cost and morbidity.
- Navigating the black box AI debate in healthcare
How concerned should healthcare stakeholders be about the complexity and lack of transparency in black box artificial intelligence tools?
- ICMR-NIRRCH To Hold Workshop On Applications of Artificial Intelligence and Machine Learning in Disease Informatics, Details
New Delhi- The Indian Council of Medical Research (ICMR) and National Institute for Research in Reproductive and Child Health (NIRRCH) are going to organise a workshop on “Applications ...
Go deeper with Google Headlines on:
Machine learning in medicine
[google_news title=”” keyword=”machine learning in medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
